T1	Participants 209 260	patients with acute severe pulmonary embolism (PE).
T2	Participants 951 963	133 patients
T3	Participants 993 1049	two patients died before treatment and two were excluded
T4	Participants 1075 1106	129 patients for final analysis
T5	Participants 1628 1638	two groups
